• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    63 Biggest Movers From Yesterday

    6/17/22 3:38:26 AM ET
    $ACIU
    $ACLX
    $ACOR
    $ADN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACIU alert in real time by email

    Gainers

    • Advent Technologies Holdings, Inc. (NYSE:ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the Greek State for the IPCEI Green HiPo project.
    • Electric Last Mile Solutions, Inc. (NASDAQ:ELMS) gained 100.3% to close at $0.2820 after declining around 15% on Wednesday. Electric Last Mile Solutions recently announced plans to file for Chapter 7 bankruptcy.
    • Sidus Space, Inc. (NASDAQ:SIDU) shares climbed 63% to close at $7.63. Sidus Space shares jumped 225% on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) jumped 54.5% to close at $0.6185 after the company announced Esteve Pharmaceuticals GmbH launched INBRIJA in Germany.
    • Heart Test Laboratories, Inc. (NASDAQ:HSCS) gained 42.4% to close at $2.42 following’s Wednesday IPO.
    • Vivakor, Inc. (NASDAQ:VIVK) gained 40.7% to close at $2.49 after the company announced it signed a definitive agreement to acquire Silver Fuels Delhi and White Claw Colorado City.
    • Cango Inc. (NYSE:CANG) jumped 40.2% to close at $3.14.
    • Pennsylvania Real Estate Investment Trust (NYSE:PEI) shares rose 34.8% to close at $5.32.
    • Decisionpoint Systems, Inc. (NYSE:DPSI) gained 34.9% to settle at $6.11.
    • Akanda Corp. (NASDAQ:AKAN) jumped 32.6% to close at $1.23.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 25.4% to close at $12.41.
    • Lytus Technologies Holdings PTV. Ltd. (NYSE:LYT) climbed 24.9% to close at $21.25. Lytus Technologies priced its IPO at $4.75 per share.
    • Zhong Yang Financial Group Limited (NASDAQ:TOP) gained 24.8% to settle at $38.70.
    • Troika Media Group, Inc. (NASDAQ:TRKA) jumped 23.8% to settle at $0.9026.
    • Akero Therapeutics, Inc. (NASDAQ:AKRO) jumped 22% to close at $10.37. Akero Therapeutics announced a $25 million equity investment by Pfizer at $9.90 per share.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) jumped 20.7% to close at $14.30.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) climbed 19.7% to settle at $0.9751.
    • Alfi, Inc. (NASDAQ:ALF) jumped 18.5% to close at $1.28.
    • CinCor Pharma, Inc. (NASDAQ:CINC) rose 18.2% to close at $17.90. CinCor Pharma recently dosed first patient in the figHTN-CKD Phase 2 clinical study of its drug candidate Baxdrostat (CIN-107) for the treatment of patients with uncontrolled hypertension and chronic kidney disease (CKD).
    • SeaChange International, Inc. (NASDAQ:SEAC) jumped 17.3% to close at $0.6101.
    • Radius Health, Inc. (NASDAQ:RDUS) gained 17.1% to settle at $8.49.
    • Selecta Biosciences, Inc. (NASDAQ:SELB) jumped 16.5% to close at $1.34. Selecta Biosciences Director Carrie Smith Cox reported a purchase of 130,000 shares at $1.15 per share.
    • NextNav Inc. (NASDAQ:NN) surged 15.6% to close at $2.97. Nextnav 10%+ owner Wocap Global Opportunity Investment Partners, L.P. reported the purchase of 8,346,571 shares at at average price of $3.93 per share in Form 4 Filing on Wednesday.
    • Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) gained 15.4% to close at $10.19.
    • VIA optronics AG (NYSE:VIAO) gained 11.6% to close at $2.51.
    • NextPlay Technologies, Inc. (NASDAQ:NXTP) rose 11.5% to settle at $0.3010.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares gained 10.8% to close at $1.33.
    • Bon Natural Life Limited (NASDAQ:BON) gained 7.9% to close at $3.70.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) shares gained 6.7% to close at $11.69 after gaining around 9% on Wednesday.

     

    Losers

    • EJF Acquisition Corp. (NASDAQ:EJFA) shares dropped 42.7% to close at $5.50.
    • Ebix, Inc. (NASDAQ:EBIX) shares tumbled 37.7% to close at $14.59 on Thursday.
    • PROG Holdings, Inc. (NYSE:PRG) declined 30.9% to close at $16.57 after the company cut FY22 adjusted EPS and sales guidance below estimates.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) fell 28.8% to close at $0.9116.
    • SpringBig Holdings (NASDAQ:SBIG) declined 28.7% to close at $3.21. springbig completed its merger with Tuatara Capital.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) fell 25.5% to close at $1.11.
    • AirSculpt Technologies, Inc. (NASDAQ:AIRS) tumbled 22.3% to close at $6.35. Morgan Stanley downgraded AirSculpt Technologies from Overweight to Equal-Weight and lowered the price target from $17 to $8.5.
    • Winc, Inc. (NYSE:WBEV) dropped 21.9% to close at $1.50.
    • Renovare Environmental, Inc. (NASDAQ:RENO) fell 21.8% to close at $0.1721.
    • Ambow Education Holding Ltd. (NYSE:AMBO) declined 21.8% to close at $0.36.
    • Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) fell 19.7% to close at $6.15.
    • Eros Media World Plc (NASDAQ:EMWP) dropped 18.3% to settle at $2.10.
    • AC Immune SA (NASDAQ:ACIU) fell 17.8% to close at $2.35 after the company announced crenezumab did not statistically significantly slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer's disease.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) dipped 17.8% to close at $0.7268. Aquestive Therapeutics announced topline results from the first three arms of Part 3 of the EPIPHAST study for its AQST-109 epinephrine oral film for allergic reactions, including anaphylaxis.
    • Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE:VLRS) fell 17.6% to close at $9.29.
    • Sonder Holdings Inc. (NASDAQ:SOND) dropped 17.4% to settle at $1.28.
    • Aspen Group, Inc. (NASDAQ:ASPU) fell 17.2% to close at $0.82.
    • StealthGas Inc. (NASDAQ:GASS) declined 17.1% to close at $3.39.
    • Beazer Homes USA, Inc. (NYSE:BZH) fell 16.9% to close at $10.65. B. Riley Securities maintained Beazer Homes USA with a Buy and lowered the price target from $23 to $19.
    • Yellow Corporation (NASDAQ:YELL) dropped 16.5% to close at $2.83.
    • FTC Solar, Inc. (NASDAQ:FTCI) fell 16.3% to settle at $4.16.
    • Outbrain Inc. (NASDAQ:OB) dropped 16.2% to close at $4.66. Jefferies maintained Outbrain with a Buy and lowered the price target from $9 to $8.
    • Shift Technologies, Inc. (NASDAQ:SFT) declined 16.2% to close at $0.6099.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) fell 15.8% to settle at $4.32.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 15.2% to close at $1.67.
    • Embark Technology, Inc. (NASDAQ:EMBK) fell 14.4% to close at $0.5575.
    • Arcellx, Inc. (NASDAQ:ACLX) fell 14% to close at $15.02. Arcellx priced an upsized underwritten follow-on offering of 7 million at $16 per share from the original 4 million shares.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 13.6% to close at $2.10.
    • Sally Beauty Holdings, Inc. (NYSE:SBH) fell 12.7% to close at $11.75 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $19 to $12.
    • Cepton, Inc. (NASDAQ:CPTN) fell 11% to close at $1.29. Cepton, is set to join the Russell 3000® Index.
    • Green Giant Inc. (NASDAQ:GGE) declined 10.9% to close at $1.06.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) fell 10.7% to close at $2.50.
    • Koninklijke Philips N.V. (NYSE:PHG) fell 9.6% to close at $20.44.
    • Missfresh Limited (NASDAQ:MF) fell 9.2% to close at $0.2249.
    Get the next $ACIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACIU
    $ACLX
    $ACOR
    $ADN

    CompanyDatePrice TargetRatingAnalyst
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/21/2026$19.00Mkt Perform → Outperform
    Raymond James
    Controladora Vuela Compania de Aviacion S.A.B. de C.V.
    $VLRS
    1/14/2026$11.00Overweight → Neutral
    Analyst
    Sally Beauty Holdings Inc. (Name to be changed from Sally Hold
    $SBH
    1/14/2026$16.00Buy → Hold
    Jefferies
    Arcellx Inc.
    $ACLX
    1/7/2026$100.00Buy
    UBS
    Arcellx Inc.
    $ACLX
    12/22/2025$100.00Overweight
    Wells Fargo
    Controladora Vuela Compania de Aviacion S.A.B. de C.V.
    $VLRS
    12/19/2025$11.00Equal Weight → Overweight
    Barclays
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    PROG Holdings Inc.
    $PRG
    12/16/2025$50.00Buy
    B. Riley Securities
    More analyst ratings

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sally Beauty upgraded by Raymond James with a new price target

    Raymond James upgraded Sally Beauty from Mkt Perform to Outperform and set a new price target of $19.00

    1/21/26 8:30:43 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    Volaris Aviation downgraded by Analyst with a new price target

    Analyst downgraded Volaris Aviation from Overweight to Neutral and set a new price target of $11.00

    1/14/26 8:28:34 AM ET
    $VLRS
    Air Freight/Delivery Services
    Consumer Discretionary

    Sally Beauty downgraded by Jefferies with a new price target

    Jefferies downgraded Sally Beauty from Buy to Hold and set a new price target of $16.00

    1/14/26 8:27:37 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Jashnani Yogesh covered exercise/tax liability with 24,217 shares, decreasing direct ownership by 5% to 496,759 units (SEC Form 4)

    4 - Airsculpt Technologies, Inc. (0001870940) (Issuer)

    2/5/26 5:45:00 PM ET
    $AIRS
    Medical/Nursing Services
    Health Care

    Director Shepherd Danny R was granted 500 shares, increasing direct ownership by 0.54% to 92,419 units (SEC Form 4)

    4 - BEAZER HOMES USA INC (0000915840) (Issuer)

    2/5/26 4:16:23 PM ET
    $BZH
    Homebuilding
    Consumer Discretionary

    EVP, Chief Commercial Officer Santos David A covered exercise/tax liability with 5,718 shares, decreasing direct ownership by 11% to 46,986 units (SEC Form 4)

    4 - RIGEL PHARMACEUTICALS INC (0001034842) (Issuer)

    2/4/26 4:21:41 PM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-13) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/19/2022. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/21/22 4:37:57 AM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    FDA Approval for TYMLOS issued to RADIUS HEALTH INC

    Submission status for RADIUS HEALTH INC's drug TYMLOS (SUPPL-10) with active ingredient ABALOPARATIDE has changed to 'Approval' on 12/22/2021. Application Category: NDA, Application Number: 208743, Application Classification: Efficacy

    12/23/21 5:39:20 PM ET
    $RDUS
    Industrial Specialties
    Consumer Discretionary

    $ACIU
    $ACLX
    $ACOR
    $ADN
    SEC Filings

    View All

    Beazer Homes USA Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - BEAZER HOMES USA INC (0000915840) (Filer)

    2/5/26 5:28:17 PM ET
    $BZH
    Homebuilding
    Consumer Discretionary

    Vivakor Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Vivakor, Inc. (0001450704) (Filer)

    2/5/26 4:32:27 PM ET
    $VIVK
    Environmental Services
    Utilities

    Amendment: SEC Form SCHEDULE 13G/A filed by Arcellx Inc.

    SCHEDULE 13G/A - Arcellx, Inc. (0001786205) (Subject)

    2/5/26 1:16:32 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel's D-Domain Binder

    -- CAR constructs representative of anito-cel (D-Domain), cilta-cel (dual VHH), and ide-cel (scFv) were assessed preclinically for tonic signaling and off-target Claudin binding -- -- No tonic signaling or off-target activity was observed with the D-Domain, supporting its unique target-specific binding profile and anito-cel's potentially best-in-class safety profile -- -- Specific off-target activity against Claudin-9 was observed with the dual VHH binder, consistent with cilta-cel's publicly available regulatory assessment reports; the D-Domain and scFv binders did not demonstrate off-target activity -- -- CAR T activation and cytokine release were observed for dual VHH and scFv bind

    2/4/26 9:00:00 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update

    DALLAS, Feb. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE:CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today published its Bitcoin production and mining operations update for January 2026. Bitcoin Mining Production and Mining Operations Update for January 2026 Metric January 2026 [1] December 2025 [1] Number of Bitcoin produced 496.35 569.0 Average number of Bitcoin produced per day 16.01 18.35 Total number of Bitcoin held [2] 7,474.6 7,528.3 Total number of Bitcoin sold 550.03 0

    2/3/26 6:00:00 AM ET
    $CANG
    Computer Software: Prepackaged Software
    Technology

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Carroll Anthony bought $101,380 worth of shares (10,638 units at $9.53), increasing direct ownership by 78% to 24,205 units (SEC Form 4)

    4 - FTC Solar, Inc. (0001828161) (Issuer)

    12/18/25 8:00:03 AM ET
    $FTCI
    Semiconductors
    Technology

    Large owner Samberg Joseph D bought $693,300 worth of shares (58,457 units at $11.86) (SEC Form 4)

    4 - NEXTNAV INC. (0001865631) (Issuer)

    11/24/25 6:34:19 PM ET
    $NN
    Industrial Machinery/Components
    Industrials

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Financials

    Live finance-specific insights

    View All

    Vivakor Signs Letter of Intent to Sell its Midstream Business in Oklahoma STACK Play for $36 Million to Olenox Industries

    Dallas, TX, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTC:VIVK) ("Vivakor" or the "Company"), an integrated provider of energy transportation, storage, reuse, and remediation service, today announced that it has executed a non-binding Letter of Intent to sell its midstream business and transportation assets of CPE Gathering MidCon, LLC ("CPE Gathering") to Olenox Industries, Inc. (NASDAQ:OLOX) for approximately $36 million. Vivakor is the owner and operator of the Omega pipeline system, an integrated crude-oil gathering, transportation, terminaling and pipeline connection platform serving the Oklahoma STACK play. The transaction, valued at approximately $36 million, will be paid i

    2/2/26 8:30:00 AM ET
    $OLOX
    $VIVK
    RETAIL: Building Materials
    Consumer Discretionary
    Environmental Services
    Utilities

    Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

    Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 with significant cashReiterates plans to submit in Canada and EU by the end of 2026Company to host investor call on February 2, 2026, at 8:00am ET WARREN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it received a Complete Response Letter (CRL) from the U

    2/2/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Opendoor 4Q25 Financial Open House: Opendoor to Report Fourth Quarter and Full Year 2025 Financial Results on February 19th, 2026

    SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. ("Opendoor") (NASDAQ:OPEN) today announced that it will report fourth quarter and full year 2025 financial results for the period ended December 31, 2025 following the close of the market on Thursday, February 19, 2026. Modernizing Investor AccessOn February 19, 2026, management will host our Financial Open House video livestream at 2:00 p.m. PT (5:00 p.m. ET) to discuss the company's business and financial results. We believe in building in the open. The Financial Open House replaces the traditional earnings conference call with a video event, including a live segment for shareholder Q&A. Shareholder Q&AWe invi

    1/30/26 9:00:00 AM ET
    $OPEN
    Real Estate
    Finance

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Leadership Updates

    Live Leadership Updates

    View All

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FTC Solar Appoints Wes Fuller VP, North America Utility Sales

    AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (NASDAQ:FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has named Wes Fuller as its Vice President of North America Utility Sales. Fuller will report to Kent James, Chief Commercial Officer for North America. "Wes has an extensive track record of commercial leadership across the renewables industry, including trackers and energy storage," said Kent James. "His expertise, leadership and deep industry relationships will be instrumental in expanding our reach and delivering innovative tracker solutions to our customers." "I am thrilled to join FTC Solar at such a

    1/13/26 8:02:00 AM ET
    $FTCI
    Semiconductors
    Technology

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $ACIU
    $ACLX
    $ACOR
    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by AC Immune SA

    SC 13G/A - AC Immune SA (0001651625) (Subject)

    12/13/24 5:15:16 PM ET
    $ACIU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by StealthGas Inc.

    SC 13D/A - StealthGas Inc. (0001328919) (Subject)

    12/9/24 3:53:05 PM ET
    $GASS
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by NextNav Inc.

    SC 13D/A - NEXTNAV INC. (0001865631) (Subject)

    12/6/24 6:03:25 PM ET
    $NN
    Industrial Machinery/Components
    Industrials